Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Tropical Medicine & International Health : TM & IH|February 23, 2008
A decade of Japanese encephalitis surveillance in Sarawak, Malaysia: 1997-2006See C Wong, Mong H Ooi, Abdul R Abdullah, et al.The New England Journal of Medicine|April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemiaMartin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.Mediterranean Journal of Hematology and Infectious Diseases|March 13, 2019
Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry ExperienceNishit Gupta, Ravikiran Pawar, Sambhunath Banerjee, et al.Cytometry. Part B, Clinical Cytometry|February 5, 2019
FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B-Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease CloneNishit Gupta, Mayur Parihar, Sambhunath Banerjee, et al.Blood|May 28, 2016
Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemiaJulie A E Irving, Amir Enshaei, Catriona A Parker, et al.Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li-Fraumeni cancer predisposition syndromeHany Ariffin, Pierre Hainaut, Anna Puzio-Kuter, et al.Haematologica|October 29, 2017
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologiesGiovanni Cazzaniga, Paola De Lorenzo, Julia Alten, et al.The Lancet. Haematology|July 5, 2023
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trialStephen P Hunger, Thai Hoa Tran, Vaskar Saha, et al.Blood|January 27, 2017
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemiaViktoras Frismantas, Maria Pamela Dobay, Anna Rinaldi, et al.Pageof 9